Factors associated with the prevalence of neonatal abstinence syndrome in West Virginia

2018 ◽  
Vol 14 (6) ◽  
pp. 445-452 ◽  
Author(s):  
Taylor Rogerson, BSc ◽  
Anthony Houston II, BA ◽  
Garrett Lyman, BS ◽  
Jenna Ogden, BS ◽  
Kevin Paschall, BS ◽  
...  
Keyword(s):  
West Virginia ◽  
Neonatal Abstinence Syndrome ◽  
Future Research ◽  
Abstinence Syndrome ◽  
Factors Associated ◽  
Opiate Use ◽  
Two Factors ◽  
Treatment Facilities ◽  
Geographic Regions ◽  
Regional Treatment

Neonatal abstinence syndrome (NAS) is a group of problems associated with withdrawal symptoms of a newborn who was exposed to maternal opiate use while in the womb. West Virginia (WV) is of utmost concern as this state exhibits among the highest rates of opioid abuse and consequently, NAS. In this manuscript, we review factors associated with the prevalence of NAS in WV. We provide evidence suggesting that states exhibiting high Medicaid participation demonstrate a high NAS rate, further associating these two factors. Although a similar trend was observed in the substate geographic regions of WV, the presence of regional treatment facilities was negatively associated with NAS prevalence in WV, possibly suggesting that the establishment and utilization of more of these facilities may reduce NAS. Future research

Multilevel factors associated with length of stay for neonatal abstinence syndrome in Florida’s NICUs: 2010–2015

2020 ◽  
Author(s):  
Chinyere N. Reid ◽  
Tara R. Foti ◽  
Alfred K. Mbah ◽  
Mark L. Hudak ◽  
Maya Balakrishnan ◽  
...  
Keyword(s):  
Length Of Stay ◽  
Neonatal Abstinence Syndrome ◽  
Abstinence Syndrome ◽  
Factors Associated

scholarly journals Methadone for Treatment of Pregnant Opiate Addicted Women: Is There a Safer Alternative? A Review of Literature

2008 ◽  
Author(s):  
Holly Tichelkamp ◽  
Thomas Parish
Keyword(s):  
Neonatal Intensive Care ◽  
Neonatal Abstinence Syndrome ◽  
Abstinence Syndrome ◽  
Review Of Literature ◽  
Methadone Dose ◽  
Intrauterine Growth ◽  
Opiate Use ◽  
Hospital Stays ◽  
Opiate Addicts ◽  
Alternative Medications

Methadone is commonly used for the treatment of pregnant opiate-addicts. But, it can have severe effects on the neonate including Neonatal Abstinence Syndrome, increased length of stay in the neonatal intensive care unit, and intrauterine growth retardation. Neonatal Abstinence Syndrome includes neurological excitability, gastrointestinal dysfunction, and autonomic signs. Because of these adverse effects, studies have been conducted to determine what can help reduce the severe complications caused by methadone. Varied dosages of methadone and alternative medications, such as buprenorphine, slow-release morphine, and others have been studied. Most of the alternative medications, especially buprenorphine, are gaining popularity in Europe where there is a growing problem of opiate use during pregnancy. In the studies comparing methadone and buprenorphine, a slight decline in symptoms of Neonatal Abstinence Syndrome as well as shorter hospital stays for the neonates exposed to buprenorphine was noted. Studies of different dosages of methadone were conducted to determine the lowest methadone dose that is both effective for the mother and safe for the neonate. All of the studies have provided information that is helping in the search for the safest and most effective treatment for opiate addiction. What is known is that helping the mother overcome the addiction is very important. So far, the data collected are not strong enough to make a conclusion on the best choice for treatment. Further research is indicated for methadone itself and also for all its possible alternatives.

scholarly journals Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013

2016 ◽  
Vol 33 (1) ◽  
pp. 92-101 ◽  
Author(s):  
Meagan E. Stabler ◽  
D. Leann Long ◽  
Ilana R. A. Chertok ◽  
Peter R. Giacobbi ◽  
Courtney Pilkerton ◽  
...  
Keyword(s):  
West Virginia ◽  
Neonatal Abstinence Syndrome ◽  
Abstinence Syndrome

Opioid-Induced Hearing Loss and Neonatal Abstinence Syndrome: Clinical Considerations for Audiologists and Recommendations for Future Research

2020 ◽  
Vol 29 (4) ◽  
pp. 701-709
Author(s):  
Khary K. Rigg ◽  
Malika S. Rigg
Keyword(s):  
Health Care ◽  
Hearing Loss ◽  
Health Care Providers ◽  
Neonatal Abstinence Syndrome ◽  
Future Research ◽  
Care Providers ◽  
Abstinence Syndrome ◽  
Opioid Misuse ◽  
Populations At Risk ◽  
Hearing Health

Purpose Over the last two decades, the number of Americans misusing opioids has reached epidemic levels. With such drastic increases in opioid misuse, audiologists are more likely to have patients with opioid-induced hearing loss or neonatal abstinence syndrome (NAS) than in previous years. More attention is needed on how these increases might influence clinical practice and such a discussion could be useful for audiologists. The goal of this article, therefore, is to summarize what is currently known regarding the relationship between opioid misuse and audiology to help guide hearing health care providers (with a particular focus on opioid-induced hearing loss and NAS). This article (a) summarizes the overlap in opioid misuse and hearing loss populations, (b) describes the evidence linking opioid misuse to hearing loss, (c) discusses clinical implications that opioid-induced hearing loss and NAS have for practicing audiologists, and (d) recommends directions for future audiological research on opioid-induced hearing loss and NAS. Conclusions There is considerable overlap between populations at-risk for hearing loss and opioid misuse. Additionally, compelling evidence exists linking opioid misuse to hearing loss, but the specific causal mechanisms remain unclear, indicating a need for additional research. This article attempts to fill a gap in the audiological literature and has the potential to serve as a guide for hearing health care providers to make more informed clinical decisions regarding patients with opioid-induced hearing loss and NAS. Clinicians may wish to consider the concerns raised in this article before intervening with such concerns, especially in the absence of best practice protocols.

scholarly journals Opioid Use in Pregnant Women and Neonatal Abstinence Syndrome—A Review of the Literature

Toxics ◽  
2019 ◽  
Vol 7 (1) ◽  
pp. 9 ◽  
Author(s):  
Fábio Martins ◽  
David Oppolzer ◽  
Catarina Santos ◽  
Mário Barroso ◽  
Eugenia Gallardo
Keyword(s):  
Scientific Community ◽  
Neonatal Abstinence Syndrome ◽  
Health Concern ◽  
Abstinence Syndrome ◽  
Review Of The Literature ◽  
Opioid Use ◽  
Research Directions ◽  
Developmental Problems ◽  
Future Goals ◽  
Opiate Use

Opiate use during pregnancy has been an increasing problem over the last two decades, making it an important social and health concern. The use of such substances may have serious negative outcomes in the newborn, and clinical and cognitive conditions have been reported, including neonatal abstinence syndrome, developmental problems, and lower cognitive performance. These conditions are common when opiates are used during pregnancy, making the prescription of these kinds of drugs problematic. Moreover, the mother may develop opiate addiction, thus, increasing the likelihood of the infant being born with any of those conditions. This paper reviews the use of opiates during pregnancy and focuses mainly on the neonatal abstinence syndrome. First, the commonly prescribed opiates will be identified, namely those usually involved in cases of addiction and/or neonatal abstinence syndrome. Second, published approaches to deal with those problems will be presented and discussed, including the treatment of both the mother and the infant. Finally, we will outline the treatments that are safest and most efficient, and will define future goals, approaches, and research directions for the scientific community regarding this problem.

scholarly journals Capturing the statewide incidence of neonatal abstinence syndrome in real time: the West Virginia experience

2018 ◽  
Vol 85 (5) ◽  
pp. 607-611 ◽  
Author(s):  
Amna Umer ◽  
Sean Loudin ◽  
Stefan Maxwell ◽  
Christa Lilly ◽  
Meagan E. Stabler ◽  
...  
Keyword(s):  
West Virginia ◽  
Real Time ◽  
Neonatal Abstinence Syndrome ◽  
Abstinence Syndrome ◽  
The West
Sign in / Sign up

Export Citation Format

Share Document